| Epub Date |
Source |
Enrichment Method |
Identified Proteins |
Identification Confidence |
Quantitation Method |
EXP/CON cutoff |
Candidate S-acylproteins |
Reference |
| 06/02/2006 |
Yeast Saccharomyces cerevisiae |
ABE |
1,557 |
≥ two peptides (XCorr ≥ 1.8 (+1), 2.5 (+2), and 3.5 (+3), and ΔCn ≥ 0.08) |
SC |
5.5 |
70 |
[14] |
| 10/30/2007 |
Rat liver mitochondria |
MLCC (azido-palmitate) |
21 |
Peptide mass fingerprinting (p<0.05) |
Gel band intensity |
n/a |
21 |
[11] |
| 12/18/2008 |
Rat embryonic cortical neurons and synaptosomes |
ABE |
1,647 (neurons); 1,337 (synaptosomes) |
≥ two peptides (XCorr ≥ 1.8 (+1), 2.5 (+2), and 3.5 (+3), and ΔCn ≥ 0.08) |
SC |
Graphic analysis |
163 (high)a)
332 (medium)b) |
[20] |
| 01/11/2009 |
Human Jurkat T cells |
MLCC (17-ODYA) |
n/a |
≥ two peptides (XCorr ≥ 1.8 (+1), 2.5 (+2), and 3.5 (+3), and ΔCn ≥ 0.08) |
SC |
5 (high)
2-5 (medium) |
125 (high)
199 (medium) |
[12] |
| 10/02/2009 |
Human prostate cancer DU145 cells |
ABE (PalmPISC) |
928 |
≥ two different peptides (p<0.05) |
SC |
6.7 (high)
3.0-6.7 (medium) |
169 (high)
224 (medium) |
[21] |
| 07/04/2010 |
Mouse dendritic DC2.4 cells |
MLCC (17-ODYA) |
n/a |
n/a |
SC |
10 (high)
5-10 (medium) |
60 (high)
97 (medium) |
[22] |
| 11/14/2010 |
Human Jurkat T cells |
MLCC (five az/alk fatty acid analogs) |
n/a |
≥ two peptides (p<0.05) |
SC |
5 (high)
3-5 (medium) |
178 (high)
194 (medium) |
[23] |
| 12/30/2010 |
Parasite Trypanosoma brucei |
ABE |
1,672 |
FDR=0.016 |
SC |
2 and QSpec FDR=0.01 |
124 |
[24] |
| 04/03/2011 |
Human cervical cancer HeLa cells |
MLCC (HDYOA) |
53 |
n/a |
SC |
n/a |
n/a |
[13] |
| 07/23/2011 |
Mouse RAW 264.7 macrophages |
ABE |
1,183 |
FDR<0.01 (≥ two unique peptides) |
SC |
n/a |
80 (FDR=0.05); 21 (FDR=0.10-0.05) |
[25] |
| 08/02/2011 |
Human platelets |
ABE (PalmPISC) |
1,300 |
FDR<0.01 |
SC |
3 |
215 |
[26] |
| 11/06/2011 |
Mouse T-cell hybridoma cells derived from BW5147 |
MLCC (17-ODYA) |
n/a |
FDR<0.01 |
SILAC2plex |
1.5 |
415 (PAc) control)
338 (Hydd) control)
338 (both) |
[27] |
| 11/11/2011 |
Mouse neural stem cells |
MLCC (17-ODYA) |
n/a |
Peptide FDR<0.01 |
SILAC2plex |
5 |
434 (PA control)
940 (Hyd control)
~300 (both) |
[28] |
| 04/10/2012 |
Human endothelial EA.hy926 cells |
ABE |
n/a |
n/a |
No |
No |
154 |
[29] |
| 05/17/2012 |
Human B lymphoid cells |
ABE |
493 |
FDR<0.01 |
SC |
Spectral index>0.54 |
139 |
[30] |
| 08/16/2012 |
Parasite Plasmodium falciparum |
ABE and MLCC (17-ODYA) |
1,752 |
FDR<0.01 |
SILAC2plex |
n/a |
353 (ABE), 176 (MLCC) |
[31] |
| 12/17/2012 |
Arabidopsis root-derived callus cells |
ABE |
924 |
FDR<0.01 |
iTRAQ4plex |
1 |
144 (high)
115 (medium) |
[32] |
| 01/01/2013 |
Mouse epididymal fat pads and 3T3-L1 adipocytes |
ABE (Acyl-TPC) |
856 |
≥ three unique peptides |
No |
No |
856 |
[19] |
| 07/02/2013 |
Yeast Schizosaccharomyces pombe |
MLCC (17-ODYA) |
n/a |
n/a |
SC |
2 |
n/a (>238) |
[33] |
| 11/07/2013 |
Mouse brain |
ABE |
~300 |
FDR<0.02 (≥ 40 peptides) |
No |
No |
~300 |
[34] |
| 12/19/2013 |
Human umbilical vein endothelial cells |
ABE |
~1,700 |
n/a |
SILAC2plex |
1.5 |
~500 |
[35] |
a): High-confidence; b): Medium-confidence; c) Palmitate; d) Hydroxylamine.